Skip to main content

DiaMedica Therapeutics Inc.

DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401040

No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in DiaMedica Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+7 vs. Q3 2024
Shares held
6.73M
+1.16M (+20.9%) vs. Q3 2024
Total value
$36.5M
+$13.3M (+57.0%) vs. Q3 2024
New holders
12
16 more added
Sold out
5
5 more reduced

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 45 institutions
Q1 2021: 41 institutionsQ2 2021: 43 institutionsQ3 2021: 34 institutionsQ4 2021: 39 institutionsQ1 2022: 34 institutionsQ2 2022: 28 institutionsQ3 2022: 26 institutionsQ4 2022: 28 institutionsQ1 2023: 25 institutionsQ2 2023: 32 institutionsQ3 2023: 36 institutionsQ4 2023: 38 institutionsQ1 2024: 32 institutionsQ2 2024: 32 institutionsQ3 2024: 40 institutionsQ4 2024: 45 institutionsQ1 2025: 57 institutionsQ2 2025: 58 institutionsQ3 2025: 78 institutionsQ4 2025: 92 institutionsQ1 2026: 99 institutionsQ2 2026: 88 institutions
Value heldQ4 2024: $36.6M
Q1 2021: $52.1MQ2 2021: $16.9MQ3 2021: $11.2MQ4 2021: $15.0MQ1 2022: $10.0MQ2 2022: $7.42MQ3 2022: $3.14MQ4 2022: $3.99MQ1 2023: $3.93MQ2 2023: $15.1MQ3 2023: $11.0MQ4 2023: $11.3MQ1 2024: $13.2MQ2 2024: $14.9MQ3 2024: $23.3MQ4 2024: $36.6MQ1 2025: $28.5MQ2 2025: $34.5MQ3 2025: $82.9MQ4 2025: $96.0MQ1 2026: $79.6MQ2 2026: $87.8M
Institutions holding DMAC and their total value by quarter
QuarterHoldersValue
Q2 202688$87.8M
Q1 202699$79.6M
Q4 202592$96.0M
Q3 202578$82.9M
Q2 202558$34.5M
Q1 202557$28.5M
Q4 202445$36.6M
Q3 202440$23.3M
Q2 202432$14.9M
Q1 202432$13.2M
Q4 202338$11.3M
Q3 202336$11.0M
Q2 202332$15.1M
Q1 202325$3.93M
Q4 202228$3.99M
Q3 202226$3.14M
Q2 202228$7.42M
Q1 202234$10.0M
Q4 202139$15.0M
Q3 202134$11.2M
Q2 202143$16.9M
Q1 202141$52.1M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q3 2024.

Institutions holding DMAC in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Cooperman Leon G1,625,000$8.82M0.33%+113,261+7.5%Added
Vanguard Group Inc1,242,107$6.74M0.00%+193,078+18.4%Added
First Manhattan Co839,081$4.56M0.01%00.0%Unchanged
Paragon Associates & Paragon Associates II Joint Venture514,784$2.80M6.46%+32,170+6.7%Added
Bleichroeder LP382,317$2.08M0.52%00.0%Unchanged
Susquehanna International Group, LLP374,845$2.04M0.00%+273,395+269.5%Added
Geode Capital Management, LLC305,751$1.66M0.00%−1,207−0.4%Reduced
Northern Trust Corp180,192$978.4K0.00%+59,902+49.8%Added
LPL Financial LLC152,000$825.4K0.00%+11,500+8.2%Added
BlackRock, Inc.107,880$585.8K0.00%+90+0.1%Added
Qube Research & Technologies Ltd94,769$514.6K0.00%+42,680+81.9%Added
Morgan Stanley87,429$474.7K0.00%−22,587−20.5%Reduced
State Street Corp85,029$461.7K0.00%+16,300+23.7%Added
Millennium Management LLC84,829$460.6K0.00%+51,139+151.8%Added
683 Capital Management, LLC76,116$413.3K0.04%+76,116New
Ronald Blue Trust, Inc.69,122$375.3K0.00%+24,875+56.2%Added
Goldman Sachs Group Inc68,948$374.4K0.00%+68,948New
Jane Street Group, LLC42,212$229.2K0.00%+42,212New
Citigroup Inc38,474$208.9K0.00%+16,377+74.1%Added
Catalyst Financial Partners LLC38,457$208.8K0.04%00.0%Unchanged
Barclays PLC27,726$150.6K0.00%+27,726New
Meridian Wealth Management, LLC27,216$147.8K0.01%+27,216New
Schonfeld Strategic Advisors LLC26,097$141.7K0.00%+26,097New
Jefferies Financial Group Inc.26,000$141.2K0.00%00.0%Unchanged
Omers Administration Corp22,500$122.2K0.00%+22,500New
Pensionmark Financial Group, LLC21,915$119.0K0.00%+21,915New
Dimensional Fund Advisors LP19,339$105.0K0.00%+2,380+14.0%Added
Stonebridge Capital Advisors LLC17,500$95.0K0.01%00.0%Unchanged
BNP Paribas Arbitrage, SA16,800$91.2K0.00%+300+1.8%Added
Citadel Advisors LLC16,113$87.5K0.00%+4,282+36.2%Added
Bank of Montreal15,560$84.5K0.00%+15,560New
Raymond James Financial Inc15,267$82.9K0.00%+15,267New
Y-Intercept (Hong Kong) Ltd14,973$81.3K0.01%+14,973New
Balyasny Asset Management LLC14,581$79.2K0.00%+14,581New
Charles Schwab Investment Management Inc13,251$72.0K0.00%00.0%Unchanged
Magnolia Capital Advisors LLC10,160$55.2K0.01%+160+1.6%Added
Massmutual Trust Co FSB4,824$26.2K0.00%00.0%Unchanged
US Bancorp4,335$23.5K0.00%00.0%Unchanged
UBS Group AG1,769$9.61K0.00%−10,970−86.1%Reduced
TD Waterhouse Canada Inc.1,070$5.80K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,055$5.73K0.00%00.0%Unchanged
Legend Financial Advisors, Inc.1,000$5.43K0.00%00.0%Unchanged
Royal Bank of Canada330$2.00K0.00%−475−59.0%Reduced
Bank of America Corp209$1.14K0.00%−4−1.9%Reduced
Cornerstone Planning Group LLC80$4850.00%00.0%Unchanged
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−9,498−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,662−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−3,263−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,118−100.0%Sold out
JPMorgan Chase & Co0$00.00%−27−100.0%Sold out
Raymond James Financial Services Advisors, Inc.––––Not filed
Naples Money Management LLC––––Not filed